Genvivo
Genvivo

Activating the patient’s immune system against their personal cancer antigens

Using GenVivo’s proprietary gene delivery technology, we create off-the-shelf immunotherapies, which are delivered intravenously, to mount a targeted attack against solid tumors.

A background photo of GenVivo
About Genvivo
content-image

We are a clinical stage company with breakthrough vector-based platforms for immunotherapeutics in oncology

We are committed to enhancing the overall patient treatment experience.

Bottles of developed medications
02-03

Creating innovative treatment options

platform
content-image
Innovative vector-based genetic medicine platform for oncology targets

Our proprietary platform aims to set new standards in safety, efficacy, specificity of target and flexibility in mRNA payloads.

 Retrovector - Labeled
Created with BioRender.com
A photo of GenVivo's team in uniform
careers
Be part of the
GenVivo team

Our philosophy is to provide growth
opportunities and a comprehensive
compensation and benefits package to
support our most valued assets, our
employees.